About
Laurence DE SCHOULEPNIKOFF joined AdBio Partners as a Venture Partner in September 2023, bringing over 25 years of experience in the pharma industry, including VC-funded biotech start-ups and large corporate organizations. She is currently CEO of Tridek-One, a biotech start-up developing CD31 agonist modalities, and has a track record of negotiating transactions, including M&A.
Sign up to see Laurence DE SCHOULEPNIKOFF's full profile
Access investment thesis, focus areas, bio, and contact details for Laurence DE SCHOULEPNIKOFF and 22,000+ other VC professionals.
AdBio Partners
Paris, FR